| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:50 UTC |
|---|
| Update Date | 2022-03-07 02:51:46 UTC |
|---|
| HMDB ID | HMDB0014861 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Methoxamine |
|---|
| Description | Methoxamine is only found in individuals that have used or taken this drug. It is an alpha-adrenergic agonist that causes prolonged peripheral vasoconstriction. It has little if any direct effect on the central nervous system. [PubChem]Methoxamine acts through peripheral vasoconstriction by acting as a pure alpha-1 adrenergic receptor agonist, consequently increasing systemic blood pressure (both systolic and diastolic). |
|---|
| Structure | COC1=CC(C(O)C(C)N)=C(OC)C=C1 InChI=1S/C11H17NO3/c1-7(12)11(13)9-6-8(14-2)4-5-10(9)15-3/h4-7,11,13H,12H2,1-3H3 |
|---|
| Synonyms | | Value | Source |
|---|
| Methoxamedrine | ChEBI | | Methoxamin | ChEBI | | Vasoxyl | HMDB | | Glaxo wellcome brand 2 OF methoxamine hydrochloride | HMDB | | Methoxamine hydrochloride | HMDB | | Vasylox | HMDB | | Glaxo wellcome brand 1 OF methoxamine hydrochloride | HMDB | | Vasoxin | HMDB | | Vasoxine | HMDB | | Wellcome brand OF methoxamine hydrochloride | HMDB | | Hydrochloride, methoxamine | HMDB | | Methoxamedrin | HMDB | | Metoxamine wellcome | HMDB | | Wellcome, metoxamine | HMDB |
|
|---|
| Chemical Formula | C11H17NO3 |
|---|
| Average Molecular Weight | 211.2576 |
|---|
| Monoisotopic Molecular Weight | 211.120843415 |
|---|
| IUPAC Name | 2-amino-1-(2,5-dimethoxyphenyl)propan-1-ol |
|---|
| Traditional Name | methoxamine |
|---|
| CAS Registry Number | 390-28-3 |
|---|
| SMILES | COC1=CC(C(O)C(C)N)=C(OC)C=C1 |
|---|
| InChI Identifier | InChI=1S/C11H17NO3/c1-7(12)11(13)9-6-8(14-2)4-5-10(9)15-3/h4-7,11,13H,12H2,1-3H3 |
|---|
| InChI Key | WJAJPNHVVFWKKL-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as dimethoxybenzenes. These are organic aromatic compounds containing a monocyclic benzene moiety carrying exactly two methoxy groups. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Benzene and substituted derivatives |
|---|
| Sub Class | Methoxybenzenes |
|---|
| Direct Parent | Dimethoxybenzenes |
|---|
| Alternative Parents | |
|---|
| Substituents | - Dimethoxybenzene
- P-dimethoxybenzene
- Phenylpropane
- Anisole
- Phenol ether
- Phenoxy compound
- Alkyl aryl ether
- Aralkylamine
- Secondary alcohol
- 1,2-aminoalcohol
- Ether
- Aromatic alcohol
- Primary amine
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Primary aliphatic amine
- Organopnictogen compound
- Amine
- Organic oxygen compound
- Alcohol
- Organic nitrogen compound
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 9.21 g/L | Not Available | | LogP | 0.8 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 2.23 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.9591 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 4.1 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 85.4 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 903.4 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 268.8 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 116.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 172.7 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 72.5 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 280.6 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 332.1 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 481.9 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 718.4 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 196.8 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 693.7 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 192.2 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 243.2 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 429.2 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 386.7 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 55.7 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Methoxamine,1TMS,isomer #1 | COC1=CC=C(OC)C(C(O[Si](C)(C)C)C(C)N)=C1 | 1765.9 | Semi standard non polar | 33892256 | | Methoxamine,1TMS,isomer #2 | COC1=CC=C(OC)C(C(O)C(C)N[Si](C)(C)C)=C1 | 1833.4 | Semi standard non polar | 33892256 | | Methoxamine,2TMS,isomer #1 | COC1=CC=C(OC)C(C(O[Si](C)(C)C)C(C)N[Si](C)(C)C)=C1 | 1801.8 | Semi standard non polar | 33892256 | | Methoxamine,2TMS,isomer #1 | COC1=CC=C(OC)C(C(O[Si](C)(C)C)C(C)N[Si](C)(C)C)=C1 | 1886.5 | Standard non polar | 33892256 | | Methoxamine,2TMS,isomer #1 | COC1=CC=C(OC)C(C(O[Si](C)(C)C)C(C)N[Si](C)(C)C)=C1 | 2248.5 | Standard polar | 33892256 | | Methoxamine,2TMS,isomer #2 | COC1=CC=C(OC)C(C(O)C(C)N([Si](C)(C)C)[Si](C)(C)C)=C1 | 1989.9 | Semi standard non polar | 33892256 | | Methoxamine,2TMS,isomer #2 | COC1=CC=C(OC)C(C(O)C(C)N([Si](C)(C)C)[Si](C)(C)C)=C1 | 2035.7 | Standard non polar | 33892256 | | Methoxamine,2TMS,isomer #2 | COC1=CC=C(OC)C(C(O)C(C)N([Si](C)(C)C)[Si](C)(C)C)=C1 | 2480.6 | Standard polar | 33892256 | | Methoxamine,3TMS,isomer #1 | COC1=CC=C(OC)C(C(O[Si](C)(C)C)C(C)N([Si](C)(C)C)[Si](C)(C)C)=C1 | 2005.4 | Semi standard non polar | 33892256 | | Methoxamine,3TMS,isomer #1 | COC1=CC=C(OC)C(C(O[Si](C)(C)C)C(C)N([Si](C)(C)C)[Si](C)(C)C)=C1 | 2031.2 | Standard non polar | 33892256 | | Methoxamine,3TMS,isomer #1 | COC1=CC=C(OC)C(C(O[Si](C)(C)C)C(C)N([Si](C)(C)C)[Si](C)(C)C)=C1 | 2257.6 | Standard polar | 33892256 | | Methoxamine,1TBDMS,isomer #1 | COC1=CC=C(OC)C(C(O[Si](C)(C)C(C)(C)C)C(C)N)=C1 | 2024.7 | Semi standard non polar | 33892256 | | Methoxamine,1TBDMS,isomer #2 | COC1=CC=C(OC)C(C(O)C(C)N[Si](C)(C)C(C)(C)C)=C1 | 2115.3 | Semi standard non polar | 33892256 | | Methoxamine,2TBDMS,isomer #1 | COC1=CC=C(OC)C(C(O[Si](C)(C)C(C)(C)C)C(C)N[Si](C)(C)C(C)(C)C)=C1 | 2296.8 | Semi standard non polar | 33892256 | | Methoxamine,2TBDMS,isomer #1 | COC1=CC=C(OC)C(C(O[Si](C)(C)C(C)(C)C)C(C)N[Si](C)(C)C(C)(C)C)=C1 | 2331.1 | Standard non polar | 33892256 | | Methoxamine,2TBDMS,isomer #1 | COC1=CC=C(OC)C(C(O[Si](C)(C)C(C)(C)C)C(C)N[Si](C)(C)C(C)(C)C)=C1 | 2506.0 | Standard polar | 33892256 | | Methoxamine,2TBDMS,isomer #2 | COC1=CC=C(OC)C(C(O)C(C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1 | 2476.2 | Semi standard non polar | 33892256 | | Methoxamine,2TBDMS,isomer #2 | COC1=CC=C(OC)C(C(O)C(C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1 | 2453.6 | Standard non polar | 33892256 | | Methoxamine,2TBDMS,isomer #2 | COC1=CC=C(OC)C(C(O)C(C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1 | 2635.0 | Standard polar | 33892256 | | Methoxamine,3TBDMS,isomer #1 | COC1=CC=C(OC)C(C(O[Si](C)(C)C(C)(C)C)C(C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1 | 2687.0 | Semi standard non polar | 33892256 | | Methoxamine,3TBDMS,isomer #1 | COC1=CC=C(OC)C(C(O[Si](C)(C)C(C)(C)C)C(C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1 | 2636.3 | Standard non polar | 33892256 | | Methoxamine,3TBDMS,isomer #1 | COC1=CC=C(OC)C(C(O[Si](C)(C)C(C)(C)C)C(C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1 | 2572.9 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental GC-MS | GC-MS Spectrum - Methoxamine GC-EI-TOF (Non-derivatized) | splash10-014i-0900000000-c18e80e68507135a55de | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - Methoxamine GC-EI-TOF (Non-derivatized) | splash10-000f-1980000000-5a3cb42851d6378d998c | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - Methoxamine GC-EI-TOF (Non-derivatized) | splash10-014i-0900000000-c18e80e68507135a55de | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - Methoxamine GC-EI-TOF (Non-derivatized) | splash10-000f-1980000000-5a3cb42851d6378d998c | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Methoxamine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-9400000000-f95f18aaa517d345558f | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Methoxamine GC-MS (1 TMS) - 70eV, Positive | splash10-000f-9170000000-5a7687b88a5e5736ea53 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Methoxamine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Methoxamine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Methoxamine LC-ESI-QQ , positive-QTOF | splash10-03dl-0690000000-5602a5d1ca570bcf9aa6 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Methoxamine LC-ESI-QQ , positive-QTOF | splash10-0006-0900000000-1b92cefe5d27ce45aad1 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Methoxamine LC-ESI-QQ , positive-QTOF | splash10-03dj-0900000000-bd56a39cbf83b4b15579 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Methoxamine LC-ESI-QQ , positive-QTOF | splash10-03kj-1900000000-4dc22029f0246da362e5 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Methoxamine LC-ESI-QQ , positive-QTOF | splash10-01bd-4900000000-5bd9da97330739f95161 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Methoxamine LC-ESI-IT , positive-QTOF | splash10-0006-0900000000-89ab0b5f7f3887939aea | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Methoxamine 20V, Negative-QTOF | splash10-0ai0-9800000000-28efb5b4aad0fd8abd82 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Methoxamine 10V, Negative-QTOF | splash10-00di-9500000000-6c71c8b0a10f1af4a6f3 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Methoxamine 40V, Negative-QTOF | splash10-0k97-5900000000-725173a2cbd2a15f8105 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Methoxamine 20V, Positive-QTOF | splash10-03fu-0900000000-0dc780e113d2bc5b1024 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Methoxamine 10V, Positive-QTOF | splash10-0006-0900000000-00f066e5e69f13588eec | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Methoxamine 40V, Positive-QTOF | splash10-05tf-6900000000-59dd8ab3029dd0ce3690 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Methoxamine 10V, Positive-QTOF | splash10-0006-0900000000-188e3234b8e8063962d8 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Methoxamine 40V, Positive-QTOF | splash10-0596-6900000000-3a39f10dd453930e5977 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Methoxamine 20V, Positive-QTOF | splash10-03dl-0900000000-9731c275bf5d63e8a01c | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Methoxamine 10V, Positive-QTOF | splash10-01ox-0940000000-d9e757b7d1068e357dec | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Methoxamine 20V, Positive-QTOF | splash10-004l-0900000000-125668ca28b2b041fda5 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Methoxamine 40V, Positive-QTOF | splash10-06vi-2900000000-6a7f29f71b196055ca17 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Methoxamine 10V, Negative-QTOF | splash10-03di-0690000000-1aa8bde9e66ac0010632 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Methoxamine 20V, Negative-QTOF | splash10-01p6-0920000000-56987f7fa245e6bbb475 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Methoxamine 40V, Negative-QTOF | splash10-06ri-2900000000-03625bf389b14ac47819 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Methoxamine 10V, Positive-QTOF | splash10-002f-0920000000-70e7df44e0d24606d1a3 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Methoxamine 20V, Positive-QTOF | splash10-0ufu-0900000000-fb436c23667d8faf38ca | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Methoxamine 40V, Positive-QTOF | splash10-000l-7900000000-ee5181b465c5fed70f2e | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Methoxamine 10V, Negative-QTOF | splash10-03di-1290000000-8c5dbabc0c59be169f69 | 2021-10-11 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum |
|
|---|